Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Seminari, E' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 13 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Regazzi, MB; Seminari, E; Villani, P; Carriero, PL; Montagna, M; Marubbi, F; Maserati, R
      Nelfinavir suspension obtained from nelfinavir tablets has equivalent pharmacokinetic profile

      JOURNAL OF CHEMOTHERAPY
    2. Regazzi, MB; Villani, P; Maserati, R; Seminari, E; Pan, A; LoCaputo, F; Gambarana, E; Fiocchi, C
      Clinical pharmacokinetics of nelfinavir combined with efavirenz and stavudine during rescue treatment of heavily pretreated HIV-infected patients

      Journal of antimicrobial chemotherapy
    3. Clerici, M; Seminari, E; Suter, F; Castelli, F; Pan, A; Biasin, M; Colombo, F; Trabattoni, D; Maggiolo, F; Carosi, G; Maserati, R
      Different immunologic profiles characterize HIV infection in highly activeantiretroviral therapy-treated and antiretroviral-naive patients with undetectable viraemia

      AIDS
    4. Lori, F; Maserati, R; Foli, A; Seminari, E; Timpone, J; Lisziewicz, J
      Structured treatment interruptions to control HIV-1 infection

      LANCET
    5. Seminari, E; Maggiolo, F; Villani, P; Suter, F; Pan, A; Regazzi, MB; Tinelli, C; Maserati, R
      Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Jahnke, N; Seminari, E; Hogg, RS; Yip, B; O'Shaughnessy, MV; Montaner, JSG
      Antiretroviral effect of two different dose regimens of ritonavir and saquinavir on HIV-infected adults in a population-based setting

      ANTIVIRAL THERAPY
    7. Seminari, E; Lisziewicz, J; Tinelli, C; Foli, A; Lori, F; Maserati, R
      Hydroxyurea toxicity combined with didanosine (ddl) in HIV-1-seropositive asymptomatic individuals

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    8. Lori, F; Rosenberg, E; Lieberman, J; Foli, A; Maserati, R; Seminari, E; Alberici, F; Walker, B; Lisziewicz, J
      Hydroxyurea and didanosine long-term treatment prevents HIV breakthrough and normalizes immune parameters

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    9. Villani, P; Regazzi, MB; Castelli, F; Viale, P; Torti, C; Seminari, E; Maserati, R
      Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patients

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    10. Maserati, R; Villani, P; Seminari, E; Pan, A; Lo Caputo, S; Regazzi, MB
      High plasma levels of nelfinavir and efavirenz in two HIV-positive patients with hepatic disease

      AIDS
    11. Villani, P; Pregnolato, M; Banfo, S; Rettani, M; Burroni, D; Seminari, E; Maserati, R; Regazzi, MB
      High-performance liquid chromatography method for analyzing the antiretroviral agent efavirenz in human plasma

      THERAPEUTIC DRUG MONITORING
    12. Forrest, DM; Seminari, E; Hogg, RS; Yip, B; Raboud, J; Lawson, L; Phillips, P; Schechter, MT; O'Shaughnessy, MV; Montaner, JSG
      The incidence and spectrum of AIDS-defining illnesses in persons treated with antiretroviral drugs

      CLINICAL INFECTIOUS DISEASES
    13. RABOUD JM; SEMINARI E; RAE SL; HARRIGAN PR; HOGG RS; CONWAY B; SHERLOCK C; SCHECHTER MT; OSHAUGHNESSY MV; MONTANER JSG
      COMPARISON OF COSTS OF STRATEGIES FOR MEASURING LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA BY USING AMPLICOR AND ULTRA DIRECT ASSAYS

      Journal of clinical microbiology (Print)


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/05/20 alle ore 21:50:01